small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 32 results

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Tax

With an international geographic reach, Winston & Strawn’s integrated tax practice addresses virtually all areas of tax law. Our group of 40 tax attorneys is well-versed in representing some of the largest public and privately-held corporations, exempt organizations, and large estates....Read more

Industry

Cryptocurrencies, Digital Assets & Blockchain Technology

As interest in digital assets continues to rise, novel and complex legal issues emerge continually. Winston’s cross-border interdisciplinary team provides comprehensive regulatory, litigation, and transactional services on the array of issues confronting the digital assets industry. Our dedicated team features pioneering attorneys in the sector, leading litigators, former senior regulators, and in-house counsel....Read more

Experience 202 results

Experience

|

August 12, 2025

US$2B Roper Technologies, Inc. Senior Notes Offering

Winston & Strawn LLP served as underwriters' counsel to BofA Securities, J.P. Morgan, and Wells Fargo Securities, as joint book-running managers, in connection with the registered public offering by Roper Technologies, Inc. of US$2B of senior notes, comprised of US$500M of its 4.250% senior notes due 2028, US$500M of its 4.450% senior notes due 2030 and US$1B of its 5.100% senior notes due 2035....Read more

Experience

|

July 15, 2025

Atsion Commits Up to $200 Million in Strategic OFA Investment

Winston & Strawn is representing Atsion Opportunity Fund LLC – Series 1 in connection with its committed equity facility of up to US$200M with OFA Group. The facility enables OFA to issue and sell ordinary shares over a 36-month period to support its cryptocurrency treasury strategy....Read more

Experience

|

July 9, 2025

BitMine Completes $20 Billion Upsize of ATM Program

Winston & Strawn LLP represented BitMine Immersion Technologies, Inc. in connection with its latest expansion of its at-the-market (ATM) equity offering, increasing the program by $20 billion to a total of $24.5 billion. BitMine (NYSE: BMNR), a former bitcoin mining company now focused on building the largest Ethereum treasury in the world, currently holds more than 1,713,899 ETH valued at over $8.2 billion. ...Read more
View All Experience

Insights & News 1,354 results

Direct Sellers Update: Regulation, Law & Policy

|

September 9, 2025

|

3 Min Read

No More Click to Cancel Rule—But FTC Enforcement Actions Keep Coming

The FTC’s much-anticipated “Click to Cancel” Rule was nixed, but the FTC is not backing down. The FTC continues to use Section 5 of the FTC Act and various other regulations to bring enforcement actions against companies that fail to provide clear and conspicuous disclosures about recurring charges and easy-to-cancel options for consumers. 

Article

|

August 25, 2025

|

7 Min Read

Adapting To USPTO’s Tighter Inter Partes Review Rules

This article was originally published in Law360. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only....Read more

Product Liability & Mass Torts Digest

|

August 22, 2025

|

5 Min Read

District Court Recognizes Loper Bright Does Not Undermine Basis for Express-Preemption Defense in Medical Device Cases

In what appears to be the first case to consider the issue, an Eastern District of Missouri court recently rejected the argument that the Supreme Court’s Loper Bright Enterprises v. Raimondo decision overruling Chevron deference undermines the basis for express preemption in medical device cases.

 

View All Insights & News

Other Results 14 results

Site Content

Opportunity & Inclusion

Site Content

Japan Practice

Location

Dallas

Opened in 2017, Winston & Strawn’s Dallas office is located in the cultural and economic epicenter of DFW, the fourth largest metropolitan area in the U.S. and the fastest growing over the last year. Our Dallas attorneys litigate both high-stakes civil and criminal matters, including major state and federal trials and appeals nationwide, and represent clients in complex transactional matters. Under the leadership of Bryan L. Goolsby, our office—made up of nearly 100 lawyers—continues to expand, attracting some of the country’s top legal talent to meet the increased needs of the many technology, investment, and health care companies that are increasingly making Dallas their home....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising